ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014

Four New Program Announcements For BRMP Trials Issued

October 22, 1982

NIH Seeking More Women, Minorities On Committees

November 9, 1979

Niccotine Reports As Aiding Metastasis

August 22, 1986

Budget Would Support 1,211 More Grants

February 7, 2003

Columnist, Kushner, Four Others Names To NCAB

May 9, 1980